Real-World Outcomes of Paliperidone Palmitate Compared to Daily Oral Antipsychotic Therapy in Schizophrenia: A Randomized, Open-Label, Review Board-Blinded 15-Month Study (vol 76, pg 554, 2015)

Alphs Larry

首页> 外文期刊>The journal of clinical psychiatry >Real-World Outcomes of Paliperidone Palmitate Compared to Daily Oral Antipsychotic Therapy in Schizophrenia: A Randomized, Open-Label, Review Board-Blinded 15-Month Study (vol 76, pg 554, 2015)

【24h】

Real-World Outcomes of Paliperidone Palmitate Compared to Daily Oral Antipsychotic Therapy in Schizophrenia: A Randomized, Open-Label, Review Board-Blinded 15-Month Study (vol 76, pg 554, 2015)

机译：Paliperidone棕榈酸盐的现实世界结果与精神分裂症中的每日口腔抗精神病药疗法相比：随机，开放标签，审查董事会蒙蔽15个月的研究（Vol 76，PG 554,2015）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The journal of clinical psychiatry》 |2019年第2期|共1页
作者
Alphs Larry;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类精神病学;
关键词

相似文献

外文文献

1. Real-World Outcomes of Paliperidone Palmitate Compared to Daily Oral Antipsychotic Therapy in Schizophrenia: A Randomized, Open-Label, Review Board-Blinded 15-Month Study (vol 76, pg 554, 2015) [J] . Alphs Larry The journal of clinical psychiatry . 2019,第2期

机译：Paliperidone棕榈酸盐的现实世界结果与精神分裂症中的每日口腔抗精神病药疗法相比：随机，开放标签，审查董事会蒙蔽15个月的研究（Vol 76，PG 554,2015）
2. Real-World Outcomes of Paliperidone Palmitate Compared to Daily Oral Antipsychotic Therapy in Schizophrenia: A Randomized, Open-Label, Review Board-Blinded 15-Month Study [J] . Alphs Larry, Benson Carmela, Cheshire-Kinney Kimberly, The journal of clinical psychiatry . 2015,第5期

机译：帕潘立酮棕榈酸酯与精神分裂症患者每日口服抗精神病药物治疗的实际结果：一项随机，开放标签，审查委员会盲目的15个月研究
3. Real-World Outcomes of Paliperidone Palmitate Compared to Daily Oral Antipsychotic Therapy in Schizophrenia: A Randomized, Open-Label, Review Boarda€“Blinded 15-Month Study [J] . Carmela Benson, H. Lynn Starr, Jean-Pierre Lindenmayer, Primary care companion to the journal of clinical psychiatry . 2015,第5期

机译：精神分裂症中帕潘立酮棕榈酸酯与每日口服抗精神病药物治疗的实际结果：随机，开放标签，审查委员会–盲法为期15个月的研究
4. Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective open-label interventional study [O] . Andreas Schreiner, Asaf Caspi, Paul Bergmans, -1

机译：非急性精神分裂症患者从口服非典型抗精神病药物单一疗法转为帕潘立酮棕榈酸酯每月一次：一项前瞻性开放性干预性研究
5. Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study [O] . Andreas Schreiner, Asaf Caspi, Paul Bergmans, 2016

机译：非急性精神分裂症患者从口服非典型抗精神病药物单一疗法转为帕潘立酮棕榈酸酯每月一次：一项前瞻性，开放性，干预性研究

Real-World Outcomes of Paliperidone Palmitate Compared to Daily Oral Antipsychotic Therapy in Schizophrenia: A Randomized, Open-Label, Review Board-Blinded 15-Month Study (vol 76, pg 554, 2015)

著录项

相似文献

相关主题

期刊订阅